Research Unit in Systematic Reviews and Meta-analysis

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Meta-Analysis 85%
3. Coronavirus 39%
4. Confidence Intervals 38%
5. Peru 37%
6. Randomized Controlled Trials 31%
7. Latin America 25%
8. Mortality 24%
9. Hydroxychloroquine 22%
10. Dyspepsia 17%
11. Odds Ratio 17%
12. Pandemics 15%
13. Hemorrhage 13%
14. Pancreatitis 13%
15. Helicobacter pylori 11%
16. Lipids 11%
17. Intention 11%
18. Therapeutics 11%
19. Network Meta-Analysis 9%
20. Hydroxymethylglutaryl-CoA Reductase Inhibitors 9%
21. Coronary Artery Disease 9%
22. Gastrointestinal Endoscopy 9%
23. APACHE 8%
24. Liraglutide 8%
25. Databases 8%
26. Vaccination 8%
27. Biopsy 8%
28. Melena 8%
29. Hematemesis 8%
30. Cohort Studies 7%
31. Autoimmune Hepatitis 7%
32. Choriocarcinoma 7%
33. Endoscopic Mucosal Resection 7%
34. Pericarditis 7%
35. Social Security 7%
36. Gastroenterology 7%
37. Myocardial Infarction 7%
38. Public Hospitals 7%
39. Observational Studies 7%
40. Chloroquine 6%
41. Shock 6%
42. Endoscopy 6%
43. Depression 6%
44. Case-Control Studies 6%
45. Lopinavir 6%
46. Dietary Supplements 6%
47. Neoplasms 6%
48. Acute Coronary Syndrome 6%
49. Placebos 6%
50. Virus Diseases 5%
51. Azithromycin 5%
52. Hospitalization 5%
53. Dietary Animal Proteins 5%
54. Hepatitis 5%
55. Practice Guidelines 5%
56. Ritonavir 5%
57. Lymphocytes 5%
58. Food Supply 5%
59. Infections 5%
60. Stomach 5%
61. Atrial Fibrillation 5%
62. origen 5%
63. Safety 5%
64. Percutaneous Coronary Intervention 5%
65. Stomach Neoplasms 5%
66. Intensive Care Units 5%
67. PubMed 5%
68. Intestinal Lymphangiectasis 5%
69. Human T-lymphotropic virus 1 5%